Home Newsfeeds ‘Amazon Plans a Stand-Alone Sports App as Andy Jassy Doubles Down on Prime Video’ -The Information

News

‘Amazon Plans a Stand-Alone Sports App as Andy Jassy Doubles Down on Prime Video’ -The Information

https://www.theinformation.com/

byBenzinga Newsdesk

December 28, 2022

1 minute read

https://www.theinformation.com/

Needham Names Axcelis Top Pick In SemiCap; Picks Monolithic Power In Semiconductors

By Anusuya Lahiri

January 5, 2:36 PM

Needham analyst Quinn Bolton maintained Axcelis Technologies Inc (NASDAQ:ACLS) with a Buy and raised the price target from $77 to $100. Bolton…

ACLS

Evercore ISI Group Initiates Coverage On Altus Power with Outperform Rating, Announces Price Target of $15

By Benzinga Newsdesk

January 4, 7:37 AM

Evercore ISI Group analyst James West initiates coverage on Altus Power (NYSE:AMPS) with a Outperform rating and announces Price Target of $15.

AMPS

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst

By Vandana Singh

January 23, 3:56 PM

Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.

ABT

SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $60

By Benzinga Newsdesk

September 30, 12:16 PM

SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $65 to $60.

RCKT

‘Amazon Plans a Stand-Alone Sports App as Andy Jassy Doubles Down on Prime Video’ -The Information

Related Posts

Needham Names Axcelis Top Pick In SemiCap; Picks Monolithic Power In Semiconductors

Evercore ISI Group Initiates Coverage On Altus Power with Outperform Rating, Announces Price Target of $15

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst

SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $60